- Home
- RVMD vs GTLB Comparison
RVMD vs GTLB Comparison
Compare RVMD & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- GTLB
- Stock Information
- Founded
- RVMD 2014
- GTLB 2011
- Country
- RVMD United States
- GTLB United States
- Employees
- RVMD N/A
- GTLB N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- GTLB EDP Services
- Sector
- RVMD Health Care
- GTLB Technology
- Exchange
- RVMD Nasdaq
- GTLB Nasdaq
- Market Cap
- RVMD 7.5B
- GTLB 7.5B
- IPO Year
- RVMD 2020
- GTLB 2021
- Fundamental
- Price
- RVMD $36.63
- GTLB $43.76
- Analyst Decision
- RVMD Strong Buy
- GTLB Buy
- Analyst Count
- RVMD 12
- GTLB 26
- Target Price
- RVMD $69.50
- GTLB $64.27
- AVG Volume (30 Days)
- RVMD 1.5M
- GTLB 3.7M
- Earning Date
- RVMD 08-06-2025
- GTLB 09-02-2025
- Dividend Yield
- RVMD N/A
- GTLB N/A
- EPS Growth
- RVMD N/A
- GTLB N/A
- EPS
- RVMD N/A
- GTLB 0.08
- Revenue
- RVMD N/A
- GTLB $804,571,000.00
- Revenue This Year
- RVMD N/A
- GTLB $26.38
- Revenue Next Year
- RVMD $234.26
- GTLB $21.20
- P/E Ratio
- RVMD N/A
- GTLB $544.53
- Revenue Growth
- RVMD N/A
- GTLB 29.31
- 52 Week Low
- RVMD $29.17
- GTLB $37.90
- 52 Week High
- RVMD $62.40
- GTLB $74.18
- Technical
- Relative Strength Index (RSI)
- RVMD 51.68
- GTLB 45.44
- Support Level
- RVMD $36.20
- GTLB $41.15
- Resistance Level
- RVMD $38.60
- GTLB $48.93
- Average True Range (ATR)
- RVMD 1.25
- GTLB 1.67
- MACD
- RVMD 0.09
- GTLB -0.27
- Stochastic Oscillator
- RVMD 56.43
- GTLB 33.55
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.